Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of combination of lamivudine and domperidone in preparation of sedative drug

A technology of domperidone and lamivudine, which is applied to the application of domperidone in combination for the preparation of sedative drugs, in the field of lamivudine, can solve the problem that the sedative effect or central nervous system inhibition effect of lamivudine or domperidone is not found, and achieves Enhance the effect of synthesis and release

Active Publication Date: 2020-06-30
ZHANG ZHOU HALTH VOCATIONAL COLLEGE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, no lamivudine or domperidone has been found to have a sedative effect or a central nervous system inhibitory effect on the human body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of combination of lamivudine and domperidone in preparation of sedative drug
  • Application of combination of lamivudine and domperidone in preparation of sedative drug
  • Application of combination of lamivudine and domperidone in preparation of sedative drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A sedative drug consisting of lamivudine and domperidone, wherein the dose of lamivudine is 19.08 mg / d, and the dose of domperidone is 6 mg / d.

Embodiment 2

[0031] A sedative drug consisting of lamivudine and domperidone, where the dose of lamivudine is 20.08 mg / d and the dose of domperidone is 5 mg / d.

Embodiment 3

[0033] A sedative drug consisting of lamivudine and domperidone, where the dose of lamivudine is 18.08 mg / d and the dose of domperidone is 7 mg / d.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of a combination of lamivudine and domperidone in preparation of a sedative drug. A study finds that the lamivudine and the domperidone can play an exact sedationrole when combined at a specific ratio; and furthermore, the lamivudine and the domperidone are relatively mild in sedation effect and do not cause a communication loss or difficulty in wake-up. A further pharmacological property study shows that the drug can promote binding of a GABA receptor and a GABAA receptor, so that the opening frequency of a chloride ion channel is increased; meanwhile, the content of glutamic acid in cerebral cortex and hypothalamus of an experimental animal is lowered, so as to reduce excitatory neurotoxicity in the brain; and furthermore, the drug can be selectively combined with a 5-hydroxytryptamine 1A receptor and inhibits uptaking of 5-hydroxytryptamine by cynapse, so as to increase the content of the 5-hydroxytryptamine. Based on the discovered new properties, a new application of the combination of the lamivudine and the domperidone the in preparation of the sedative drug is determined, so that the optional range of the sedative drug is expanded and the sedation effect is improved to a certain extent.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry, and further relates to the new medical application of substances, in particular to the application of lamivudine and domperidone in combination for the preparation of sedative drugs. Background technique [0002] Sedatives are a general term for a large class of drugs that promote calmness and sleep in the human body. They are mainly used for the symptomatic treatment of symptoms such as mental disorders, anxiety and irritability. Ideal sedative drugs need to have the following characteristics: 1. Little impact on circulation and breathing: 2. The effect is fast and the effect is obvious; 3. The drug is metabolized quickly and basically has no obvious accumulation effect; 4. It has little effect on liver and kidney functions; 5. It has excellent anti-anxiety and compliant amnesia effects, and it is easy to wake up when using it. At present, the commonly used sedatives mainly include b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/513A61K31/728A61P25/20A61K31/454A61K31/455A61K31/7048
CPCA61K31/454A61K31/455A61K31/513A61K31/7048A61K31/728A61P25/20A61K2300/00
Inventor 颜晓萍戴云翔李嫣妮郑文忠
Owner ZHANG ZHOU HALTH VOCATIONAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products